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Section S1: Ligand selection A large dataset of CYP3A4 inhibitors was extracted from the ChEMBL database and the Lipophilic efficiency (LipE) and Ligand efficiency (LE) calculations were performed for the selection of highly potent inhibitors of CYP3A4 subtype. The ligand efficiency metrics provide an estimation of the lipophilicity, size and overall molecular properties that determine the binding affinity of a drug towards its particular target [1] . The LipE parameter provides the normalization of the potency (pIC50) for a compound's lipophilicity (clogP/logD) against a particular target and is calculated by subtracting clogP/logD from the pIC50 (equation1). For LipE profiling the clogP values were calculated using fragment based method implemented in Bio-Loom software package [2] .
The Ligand efficiency metric delivers a balance of potency and molecular size in terms of a ligand binding to its target and is measured as the ratio of binding free energy (ΔG) to the number of heavy atoms (HA) [3] . Free energies (ΔG) for CYP3A4 inhibitors were calculated using equation 2 where, R is the gas constant and T is the absolute temperature. 
= − (eq 2)
A temperature of 310K was used to compute Ligand efficiencies of the CYP3A4 inhibitors in kcal/mol/heavy atom using equation 3.
Reynolds fitting procedure [5] was adopted to achieve a size independent fit quality score (LigE_Scale) for the CYP3A4 inhibitor dataset. This was accomplished using a modified exponential function to fit top Ligand efficiencies against the number of heavy atoms (eq 4). The 
